Many challenges exist in lateral flow assay (LFA) manufacturing, from low-volume liquid deposition to device assembly and packaging. In the development and batch-level manufacturing stage, antibody ...

The global lateral flow assay (LFA) market is projected to grow from USD 10.01 billion in 2024 to USD 15.42 billion by 2030, driven by increasing demand for point-of-care testing and the rising ...

Medical device OEMs in search of commercialization and manufacturing solutions for lateral flow immunoassay (LFI) and medical diagnostic devices will discover several new capabilities and services ...

SYGNIS AG, under the Innova Biosciences (Innova) brand name, a specialist provider of bioconjugation products and services, today announced it has established a partnership with Abingdon Health Ltd ...

Lateral flow tests have transformed global healthcare by enabling rapid disease detection and improving access to medical diagnostics. However, their widespread, single-use design is creating an ...

Add Yahoo as a preferred source to see more of our stories on Google. As a result of the rapidly-spreading Omicron variant, Covid case numbers have continued to rise across the UK in record numbers, ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

Editor's Note: Article updated with latest information on availability of tests. People faced problems getting hold of the tests last week after a huge surge in demand prompted the Government website ...

This will provide a significant increase in its manufacturing footprint, resulting in Europe’s largest capacity for rapid test manufacturing. This news comes weeks after the UK Government announced ...